机构名称：
¥ 2.0
全部处方信息：含量* 1.1早期乳腺癌的辅助治疗1.2早期乳腺癌早期辅助治疗1.3对晚期乳腺癌的第一和二线治疗2 2.1剂量2.1建议2.1使用剂量2.2在辅助治疗早期乳腺癌治疗早期乳腺癌治疗中的早期乳腺癌治疗2. 3在乳腺癌的治疗中2.4在乳腺癌的治疗中2. 4 2. 4 22 Renal Impairment 3 DOSAGE FORMS AND STRENGTHS 4 CONTRAINDICATIONS 5 WARNINGS AND PRECAUTIONS 5.1 Bone Effects 5.2 Cholesterol 5.3 Hepatic Impairment 5.4 Fatigue and Dizziness 5.5 Laboratory Test Abnormalities 5.6 Embryo-Fetal Toxicity 6 ADVERSE REACTIONS 6.1 Clinical Trials Experience 6.2 Postmarketing Experience 7 DRUG INTERACTIONS 8 USE IN SPECIFIC POPULATIONS
参考ID：5496852 -AccessData.fda.gov
主要关键词
相关文件推荐
